The Prevalence of ESBL-producing Enterobacteriaceae in a Nursing Home Setting Compared with Elderly Living at Home: a Cross-sectional Comparison

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2016 Mar 6

PMID 26944857

Citations 18

Authors

Andreas Blom

Jonas Ahl

Fredrik Mansson

Fredrik Resman

Johan Tham

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the study was to investigate the prevalence of faecal carriage of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among residents living in nursing homes and to compare it with a corresponding group of elderly people living in their own homes.

Methods: A total of 160 persons participated in the study between February and April 2014, 91 were residents in nursing homes (n = 10) and the remaining 69 were elderly living in their own homes. In addition to performing faecal samples, all participants answered a standardized questionnaire regarding known risk factors for ESBL-carriage.

Results: There was no significant difference between the groups, as 10 of the 91 (11%) residents from nursing homes were ESBL-carriers compared with 6 of 69 (8,7%) elderly living in their own homes. There was no significant difference between the groups. The total prevalence was 10%. A univariate analysis revealed that the only studied risk factor significantly associated with ESBL-carriage was recent foreign travel (p = 0,017). All ESBL-positive isolates were Escherichia coli and there was a high degree of co-resistance to other antibiotics. All isolates (n = 17) were susceptible to imipenem and amikacin.

Conclusion: Residents of nursing homes as well as elderly living in their own homes have high rates of faecal carriage of ESBL-producing bacteria. These findings may affect the choice of empirical antibiotic treatment of severe infections in older adults.

Citing Articles

Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing in human stool.

Gallichan S, Forrest S, Picton-Barlow E, McKeown C, Moore M, Heinz E Microbiol Spectr. 2024; 13(1):e0105824.

PMID: 39576089 PMC: 11705872. DOI: 10.1128/spectrum.01058-24.

One decade of point-prevalence surveys for carriage of extended-spectrum beta-lactamase-producing enterobacterales: whole genome sequencing based prevalence and genetic characterization in a large Dutch teaching hospital from 2013 to 2022.

Houkes K, Weterings V, van den Bijllaardt W, Tinga M, Mulder P, Kluytmans J Antimicrob Resist Infect Control. 2024; 13(1):102.

PMID: 39267161 PMC: 11396308. DOI: 10.1186/s13756-024-01460-y.

Empirical treatment and mortality in bacteremia due to extended spectrum β-lactamase producing Enterobacterales (ESβL-E), a retrospective cross-sectional study in a tertiary referral hospital from Colombia.

Arias Ramos D, Alzate J, Moreno Gomez G, Hoyos Pulgarin J, Olaya Gomez J, Cortes Bonilla I Ann Clin Microbiol Antimicrob. 2023; 22(1):13.

PMID: 36797734 PMC: 9933341. DOI: 10.1186/s12941-023-00566-2.

The Causes and Control Measures of Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae in Long-Term Care Facilities: A Systematic Review and Meta-Analysis.

Sule I, Mendelsohn A, Panas R Health Serv Res Manag Epidemiol. 2022; 9:23333928221131709.

PMID: 36277608 PMC: 9580105. DOI: 10.1177/23333928221131709.

Antibiotic Exposure during the Preceding Six Months Is Related to Intestinal ESBL-Producing Enterobacteriaceae Carriage in the Elderly.

Zhang M, Qin X, Ding B, Shen Z, Sheng Z, Wu S Antibiotics (Basel). 2022; 11(7).

PMID: 35884207 PMC: 9312271. DOI: 10.3390/antibiotics11070953.

References

Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W . Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004; 23(3):163-7. DOI: 10.1007/s10096-003-1084-2. View

Schwaber M, Carmeli Y . Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007; 60(5):913-20. DOI: 10.1093/jac/dkm318. View

Andersson H, Lindholm C, Iversen A, Giske C, Ortqvist A, Kalin M . Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012; 44(9):641-9. DOI: 10.3109/00365548.2012.671956. View

Chabok A, Tarnberg M, Smedh K, Pahlman L, Nilsson L, Lindberg C . Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections. Scand J Gastroenterol. 2010; 45(10):1203-10. DOI: 10.3109/00365521.2010.495417. View

Stromdahl H, Tham J, Melander E, Walder M, Edquist P, Odenholt I . Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011; 30(10):1159-62. DOI: 10.1007/s10096-011-1202-5. View

Jans B, Schoevaerdts D, Huang T, Berhin C, Latour K, Bogaerts P . Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013; 8(5):e64908. PMC: 3667831. DOI: 10.1371/journal.pone.0064908. View

Rooney P, OLeary M, Loughrey A, McCalmont M, Smyth B, Donaghy P . Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother. 2009; 64(3):635-41. DOI: 10.1093/jac/dkp220. View

Rodriguez-Bano J, Lopez-Cerero L, Navarro M, Diaz de Alba P, Pascual A . Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008; 62(5):1142-9. DOI: 10.1093/jac/dkn293. View

Woerther P, Burdet C, Chachaty E, Andremont A . Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013; 26(4):744-58. PMC: 3811232. DOI: 10.1128/CMR.00023-13. View

10.

Giske C, Monnet D, Cars O, Carmeli Y . Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2007; 52(3):813-21. PMC: 2258516. DOI: 10.1128/AAC.01169-07. View

11.

Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H . Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors. Int J Med Microbiol. 2013; 303(8):405-9. DOI: 10.1016/j.ijmm.2013.05.002. View

12.

Pitout J . Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010; 70(3):313-33. DOI: 10.2165/11533040-000000000-00000. View

13.

Van Aken S, Lund N, Ahl J, Odenholt I, Tham J . Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia. Scand J Infect Dis. 2014; 46(11):753-62. DOI: 10.3109/00365548.2014.937454. View

14.

Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E . Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis. 2010; 42(4):275-80. DOI: 10.3109/00365540903493715. View

15.

Hilty M, Betsch B, Bogli-Stuber K, Heiniger N, Stadler M, Kuffer M . Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012; 55(7):967-75. PMC: 3436924. DOI: 10.1093/cid/cis581. View

16.

Brolund A, Edquist P, Makitalo B, Olsson-Liljequist B, Soderblom T, Tegmark Wisell K . Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011. Clin Microbiol Infect. 2013; 20(6):O344-52. DOI: 10.1111/1469-0691.12413. View

17.

Oteo J, Perez-Vazquez M, Campos J . Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010; 23(4):320-6. DOI: 10.1097/qco.0b013e3283398dc1. View

18.

Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout J, Quentin C, Calbo E . A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009; 49(5):682-90. DOI: 10.1086/604713. View

19.

Valverde A, Grill F, Coque T, Pintado V, Baquero F, Canton R . High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008; 46(8):2796-9. PMC: 2519510. DOI: 10.1128/JCM.01008-08. View

20.

Pitout J, Laupland K . Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3):159-66. DOI: 10.1016/S1473-3099(08)70041-0. View